Reducing Opioid Overdoses – You Can Improve Access to Naloxone - Canadian Council On Continuing Education In Pharmacy (CCCEP)
Eleven Canadians lost their life each day due to opioids in the first half of 2018. It is estimated that the number of opioid-related deaths is likely to continue to increase to 82,000 by 2025.
Opioid-related harms are not solely caused by illicit opioids but are also commonly due to prescription opioids dispensed every day in pharmacy practice. With many of the individuals having an active opioid prescription at the time of their death, pharmacists need to screen patients on prescription opioids, assess the risks of overdose, and regularly recommend take-home naloxone kits in case of an emergency. This program will provide pharmacists with practical tools to help identify patients at risk of opioid-related overdose, review the different naloxone formulations and discuss how to approach patients in their practice.
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1 CEU. CCCEP File Number: 1066-2019-2740-I-P
Michael Boivin, B. Pharm., CDE, CTE, CTH
Carole Dion, BSc. Pharm, R.Ph
Mark Barnes, BSc Chem, BSc Pharm, RPh
After successful completion of the program, the participant will be able to:
- Review risk factors which increase the risk of overdose from prescription opioids;
- Approach patients at risk of opioid-related harm to discuss the benefits of naloxone rescue therapy;
- Examine the differences between injectable and nasal naloxone therapy options;
- Discuss the role and responsibilities of the pharmacist to reduce opioid-related overdoses due to prescription opioids.